Benign prostatic hyperplasia - etiology, clinical features and management. Historical and contemporary aspects
- 1 June 2023
- journal article
- research article
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- No. 2,p. 40-50
Abstract
Introduction. Benign prostatic hyperplasia and chronic prostatitis are the most common conditions in men, the frequency of which varies with age. Chronic prostatitis (infectious or inflammatory) has a frequency of 8-35% in patients aged 20-50 years, reaching a maximum of 60-70% in those aged over 50 years. Materials and methods. Materials for the study served the medical literature regarding benign prostatic hyperplasia and chronic inflammation, published in the local and international scientific journals. Scientific databases like Cochrane Library, Medline, Scopus, Medicus, NCBI, PubMed, Google Scholar were used to find the necessary articles. Research methods – analysis, synthesis, systematization, and description. Results. After analyzing the available data, a review of the literature was conducted which highlighted both the strong and weak points of the historical medical approaches to addressing benign prostatic hyperplasia, as well as the ontogenetics and anatomical characteristics of the prostate gland. This included examining the incidence rates, concepts of causation and development, principles of diagnosis and classification of benign prostatic hyperplasia. The review also revealed the pros and cons of using mini-invasive treatment strategies versus traditional transvesical approaches in treating this condition, as well as the ongoing and significant socioeconomic impact in underdeveloped countries. Conclusions. There remains the issue of reducing intra- and post-operative complications after benign prostatic hyperplasia surgery, especially a voluminous one, which imposes itself as a very critical problem in the development of an effective treatment strategy. For the first time, a problem was described by assessing the particularities of some biochemical criteria at local surgical site and in blood serum, histological - at the level of nodular prostatic hyperplasia and at the border of the surgical site. This requires a complex correlational study to assess the biochemical, histological and immunohistochemical parameters, including the evaluation of the associations or coexistence of benign prostatic hyperplasia and chronic prostatitis.Keywords
This publication has 51 references indexed in Scilit:
- Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstructionWorld Journal of Urology, 2021
- Pooled Aquablation Results for American Men with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia in Large Prostates (60–150 cc)Advances in Therapy, 2018
- Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartmentDifferentiation, 2013
- Role of interleukins, IGF and stem cells in BPHDifferentiation, 2011
- The Current Role of Open Surgery in BPHEAU-EBU Update Series, 2006
- Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase‐2, Bcl‐2, and cell proliferation in the glandular epitheliumThe Prostate, 2004
- Prostatakarzinom (PC) - eine organspezifische Neoplasie aus der Sicht der PathologieDer Radiologe, 2003
- Increased expression of lymphocyte‐derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferationThe Prostate, 2002
- Differential expression of interleukin‐15, a pro‐inflammatory cytokine and T‐cell growth factor, and its receptor in human prostateThe Prostate, 2001
- Basic FGF, EGF, and PDGF modify TGFβ-induction of smooth muscle cell phenotype in human prostatic stromal cellsThe Prostate, 1998